Documents
Consultation on the Projected Impact and Cost-Effectiveness of Long-Acting Injectable Lenacapavir as Pre-Exposure Prophylaxis
06 June 2025
UNAIDS and the Gates Foundation convened a meeting on 5-6 June, 2025 to consider mathematical modelling evidence on the anticipated epidemiologic impact and cost-efficiency of long-acting injectable lenacapavir (LEN) for HIV prevention in low- and middle-income countries.
